2LBA Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study

Authors:
  • ASA. Stopeck
    A. Stopeck
  • JBJ.J. Body
    J.J. Body
  • YFY. Fujiwara
    Y. Fujiwara
  • ALA. Lipton
    A. Lipton
  • GSG.G. Steger
    G.G. Steger
  • MVM. Viniegra
    M. Viniegra
  • MFM. Fan
    M. Fan
  • ABA. Braun
    A. Braun
  • RDR. Dansey
    R. Dansey
  • SJS. Jun
    S. Jun

Abstract
No abstract available